FDA to decide on fate of MS drug
The FDA will convene a panel of outside experts March 7 to decide whether to allow multiple sclerosis drug Tysabri ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.